R&D | December 05, 2025
Industry-academia partnership key to advancing R&D agenda, says Dr. Jitendra Singh
Growing patent filings and tier-2 innovators reflect expanding national research base
Growing patent filings and tier-2 innovators reflect expanding national research base
Angelini Ventures has already invested €125 million in 22 startups
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
Pharmaplan brings a pan-European footprint of locations and specialist teams, now operating within Exyte’s Biopharma & Life Sciences division
The deal, backed by Gavi and executed by UNICEF, could generate up to US$90 million in savings—enough to provide more than 30 million additional doses
A key highlight will be Brenntag’s qualified amino acids portfolio
This marks Lupin’s first commercial product leveraging PrecisionSphere, a proprietary long-acting injectable (LAI) technology
The new company aims to transform cutting-edge, highly scalable technologies into innovative drug discovery platforms
The company plans to use the funds to enhance its technology and forge new strategic partnerships with surgical robotics companies
Adjusted EBITDA increased by 12.3 per cent to $531 million, up from $516 million in the same period last year
Subscribe To Our Newsletter & Stay Updated
